Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer
Carmen Criscitiello(University of Milan), Giuseppe Curigliano(European Institute of Oncology), Patrick Maisonneuve(European Institute of Oncology), Andrea Vingiani(Istituti di Ricovero e Cura a Carattere Scientifico), Giulia Viale(Istituti di Ricovero e Cura a Carattere Scientifico)
Cited by 102
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k